Analysts are estimating that Takeda Pharmaceutical will report an earnings per share (EPS) of $0.47. The market awaits Takeda Pharmaceutical's announcement, with hopes high for news of surpassing ...

Discover why Takeda Pharmaceutical Company Limited remains a solid Buy. Click to explore TAK and its drug pipeline, growth ...

NET PROFIT FORECAST: Takeda's net profit is expected to have declined 0.4% from a year earlier to 94.89 billion yen, equivalent to $642.6 million, for the three months ended June 30, according to a ...

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ...

Takeda offers strong cash flow, solid growth in key areas, and a 4.4% yield, but trades at a premium despite its fundamentals. Read why TAK stock is a hold.

Hernán’s appointment comes at a pivotal moment as Takeda intensifies its focus on advancing sustainable, value-based ...

The FDA granted 510(k) clearance to two devices, HyHub and HyHub Duo, that act as docking stations for dual vial units to ...

Positive late-stage study results position the company to file for clearance of what could be the first narcolepsy drug that ...

With the upcoming AIG Women’s Open coming up to cap off the 2025 season’s majors, here are the top contenders to watch.

How to watch the 2025 AIG Women's Open at Royal Porthcawl, including a full AIG Women's Open TV schedule, streaming info and ...

Alkermes outlined plans to move its NT1 drug candidate, alixorexton, into phase 3 after posting results from the midstage ...

Kenshi (Kenjustsu) vs Takeda (Shirai Ryu) Me Second Fight: 3:14 Takeda (Shirai Ryu) Me vs Shinnok (Imposter) Third Fight: ...